CA2065842A1 - Process for inactivating viruses in blood and blood products - Google Patents

Process for inactivating viruses in blood and blood products

Info

Publication number
CA2065842A1
CA2065842A1 CA 2065842 CA2065842A CA2065842A1 CA 2065842 A1 CA2065842 A1 CA 2065842A1 CA 2065842 CA2065842 CA 2065842 CA 2065842 A CA2065842 A CA 2065842A CA 2065842 A1 CA2065842 A1 CA 2065842A1
Authority
CA
Canada
Prior art keywords
blood
products
inactivating viruses
blood products
adsorbents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2065842
Other languages
French (fr)
Other versions
CA2065842C (en
Inventor
Harald Mohr
Bernd Lambrecht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Blutspendedienst der Landsverbande des Deutschen Roten Kreuses
Original Assignee
Harald Mohr
Bernd Lambrecht
Blutspendedienst Der Landesverbande Des Deutschen Roten Kreuzes Niedersachsen, Oldenburg Und Bremen G.G.M.B.H.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6389298&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2065842(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Harald Mohr, Bernd Lambrecht, Blutspendedienst Der Landesverbande Des Deutschen Roten Kreuzes Niedersachsen, Oldenburg Und Bremen G.G.M.B.H. filed Critical Harald Mohr
Publication of CA2065842A1 publication Critical patent/CA2065842A1/en
Application granted granted Critical
Publication of CA2065842C publication Critical patent/CA2065842C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02—Blood transfusion apparatus
    • A61M1/0209—Multiple bag systems for separating or storing blood components
    • A61M1/0218—Multiple bag systems for separating or storing blood components with filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A61M1/3686—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents by removing photoactive agents after irradiation

Abstract

The invention relates to a process for the selective removal of photodynamic substances from blood and blood products, where the purification takes place on adsorbents. An arrangement which has proved particularly advantageous for this purpose is one in which the blood or the relevant blood fraction is passed over a separating column which contains the adsorbent.
CA002065842A 1989-09-13 1990-09-08 Process for inactivating viruses in blood and blood products Expired - Lifetime CA2065842C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DEP3930510.4 1989-09-13
DE3930510A DE3930510A1 (en) 1989-09-13 1989-09-13 PROCESS FOR INACTIVATING VIRUSES IN BLOOD AND BLOOD PRODUCTS
PCT/DE1990/000691 WO1991003933A1 (en) 1989-09-13 1990-09-08 Process for inactivating viruses in blood and blood products

Publications (2)

Publication Number Publication Date
CA2065842A1 true CA2065842A1 (en) 1991-03-14
CA2065842C CA2065842C (en) 1999-12-21

Family

ID=6389298

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002065842A Expired - Lifetime CA2065842C (en) 1989-09-13 1990-09-08 Process for inactivating viruses in blood and blood products

Country Status (14)

Country Link
EP (2) EP0491757B2 (en)
JP (1) JP2965695B2 (en)
AT (1) ATE161681T1 (en)
AU (1) AU635068B2 (en)
CA (1) CA2065842C (en)
CS (1) CS76692A3 (en)
DE (3) DE3930510A1 (en)
DK (1) DK0491757T4 (en)
ES (1) ES2113347T5 (en)
FI (1) FI99192C (en)
HU (1) HU215131B (en)
NO (1) NO300911B1 (en)
RU (1) RU2036235C1 (en)
WO (1) WO1991003933A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6951713B2 (en) 1997-01-06 2005-10-04 Cerus Corporation Absorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
US7037642B2 (en) 1997-01-06 2006-05-02 Cerus Corporation Removing compounds from blood products with porous particles immobilized in a matrix
US7611831B2 (en) 1998-01-06 2009-11-03 Cerus Corporation Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571666A (en) * 1988-10-28 1996-11-05 Oklahoma Medical Research Foundation Thiazine dyes used to inactivate HIV in biological fluids
US6348309B1 (en) * 1989-09-13 2002-02-19 Blutspendedienst Der Landesverbaende Des Deutschen Roten Kreuzes Niedersachsen, Oldenburg Und Bremen G.G.M.B.H. Process for inactivating viruses in blood and blood products
US6187572B1 (en) 1990-04-16 2001-02-13 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
US6251644B1 (en) 1990-04-16 2001-06-26 Baxter International, Inc. Method for inactivating non-enveloped viral contaminants with a photosensitizer by increasing viral permeability to the photosensitizer
US5120649A (en) * 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
DE9102709U1 (en) * 1991-03-07 1991-05-23 Blutspendedienst Der Landesverbaende Des Deutschen Roten Kreuzes Niedersachsen, Oldenburg Und Bremen Gemeinnuetzige Gmbh, 3257 Springe, De
WO1996014740A1 (en) 1992-03-02 1996-05-23 Cerus Corporation Synthetic media for blood components
US6433343B1 (en) 1992-03-02 2002-08-13 Cerus Corporation Device and method for photoactivation
US6207107B1 (en) * 1992-10-05 2001-03-27 Baxter International Inc. Steam sterilizable system for inactivating viral contaminants in body fluids
CA2165065A1 (en) * 1993-06-23 1995-01-05 Henrietta Margolis-Nunno System for viral inactivation of blood
US6420570B1 (en) 1993-06-28 2002-07-16 Cerus Corporation Psoralen compounds
US5399719A (en) 1993-06-28 1995-03-21 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
US5712085A (en) 1993-06-28 1998-01-27 Cerus Corporation 5'-(4-amino-2-oxa)butye-4,4', 8-trinethylpsoralen in synthetic medium
US6319662B1 (en) * 1993-12-17 2001-11-20 Baxter International Inc. Method and apparatus for removing viral contaminants from a body fluid
WO1995018665A1 (en) * 1994-01-10 1995-07-13 Hemasure, Inc. Device and process for removing leukocytes and viral inactivating agents from blood
US5639376A (en) * 1994-01-10 1997-06-17 Hemasure, Inc. Process for simultaneously removing leukocytes and methylene blue from plasma
DE4444045C2 (en) * 1994-12-10 1997-04-17 Behringwerke Ag Method for inactivating viruses using acridine or acridine derivatives
US6544727B1 (en) 1995-06-07 2003-04-08 Cerus Corporation Methods and devices for the removal of psoralens from blood products
AT406778B (en) * 1996-04-09 2000-09-25 Immuno Ag METHOD FOR DISINEGRATING NUCLEIC ACIDS AND PRODUCING QUALITY-ASSURED BIOLOGICAL PRODUCTS
GB2322707B (en) * 1996-06-17 2000-07-12 Mercury Diagnostics Inc Electrochemical test device and related methods
US5922278A (en) * 1996-11-19 1999-07-13 Baxter International Inc. Method and apparatus for inactivating contaminants in biological fluid
US6190609B1 (en) 1996-11-19 2001-02-20 Baxter International Inc. Methods and apparatus for inactivating contaminants in biological fluid
JP2003525848A (en) * 1997-11-20 2003-09-02 セラス コーポレーション Novel psoralen for inactivating pathogens
US6610436B1 (en) 1998-09-11 2003-08-26 Gore Enterprise Holdings Catalytic coatings and fuel cell electrodes and membrane electrode assemblies made therefrom
DE19904088A1 (en) 1999-02-02 2000-09-07 Fressenius Hemocare Gmbh Tubing set for a cell separator for separating blood into its components and method for separating blood into its components
DE19914850A1 (en) * 1999-04-01 2000-10-05 Gerhard Saalmann Device for inactivating viruses, especially human immunodeficiency virus (HIV) from blood products, uses coloring agents and radiation
US6565802B1 (en) 1999-06-03 2003-05-20 Baxter International Inc. Apparatus, systems and methods for processing and treating a biological fluid with light
US6268120B1 (en) 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
US7985588B2 (en) 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
US7648699B2 (en) 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
TW590780B (en) 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
DE10031851B4 (en) * 2000-07-04 2005-10-13 Blutspendedienst der Landesverbände des Deutschen Roten Kreuzes Niedersachsen, Sachsen-Anhalt, Thüringen, Oldenburg und Bremen gGmbH Photodynamic treatment and UV-B irradiation of a platelet suspension
JP4704684B2 (en) * 2002-02-01 2011-06-15 カリディアンビーシーティ バイオテクノロジーズ，エルエルシー Reduction of contamination in blood and blood products using photosensitizers and peak wavelengths of light
CN105765064B (en) * 2014-05-23 2020-03-13 奥维克·莱昂纳多维奇·姆克尔强 Method for inactivating viruses comprising RNA and DNA on medical devices and apparatus for carrying out the method

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2827109C2 (en) * 1977-06-24 1986-10-30 Asahi Kasei Kogyo K.K., Osaka Method and device for the separation of organic compounds from plasma proteins of the blood
JPS5665071A (en) * 1979-11-01 1981-06-02 Asahi Chem Ind Co Ltd Photo-oxidation treating agent
US4748120A (en) * 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4727027A (en) * 1983-05-02 1988-02-23 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
JPS61275228A (en) * 1985-03-14 1986-12-05 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド Photodynamic inactivity of virus in therapeutical protein composition
US4775625A (en) * 1986-11-21 1988-10-04 The Medical College Of Wisconsin, Inc. Inactivating enveloped viruses with a merocyanine dye
DE3717951C1 (en) * 1987-05-25 1988-11-24 Shanmugam Murugavel Use of silica gel to detoxify blood
US4878891A (en) * 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
DE3805459A1 (en) * 1988-02-22 1989-08-31 Biotest Pharma Gmbh METHOD FOR STERILIZING BLOOD, PLASMA, BLOOD AND PLASMA DERIVATIVES, CELL SUSPENSIONS OR THE LIKE
US5149718A (en) * 1989-01-19 1992-09-22 New York University Biological fluid purification system
ES2032742T3 (en) * 1989-05-11 1997-02-01 Oklahoma Med Res Found ANTIVIRAL THERAPY USING TIAZINE AND XANTHEN BASED DYES.

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6951713B2 (en) 1997-01-06 2005-10-04 Cerus Corporation Absorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
US7037642B2 (en) 1997-01-06 2006-05-02 Cerus Corporation Removing compounds from blood products with porous particles immobilized in a matrix
US7611831B2 (en) 1998-01-06 2009-11-03 Cerus Corporation Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
US9259525B2 (en) 1998-01-06 2016-02-16 Cerus Corporation Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix

Also Published As

Publication number Publication date
NO920834D0 (en) 1992-03-03
HU9200627D0 (en) 1992-05-28
DK0491757T3 (en) 1998-09-07
NO300911B1 (en) 1997-08-18
DK0491757T4 (en) 2002-04-22
HU215131B (en) 1998-09-28
DE122008000026I1 (en) 2008-08-21
EP0491757B2 (en) 2002-01-09
ES2113347T5 (en) 2002-09-16
AU6339190A (en) 1991-04-18
EP0593098A2 (en) 1994-04-20
DE3930510A1 (en) 1991-03-21
FI99192B (en) 1997-07-15
CA2065842C (en) 1999-12-21
HUT60142A (en) 1992-08-28
AU635068B2 (en) 1993-03-11
JPH05500366A (en) 1993-01-28
DE59010793D1 (en) 1998-02-12
WO1991003933A1 (en) 1991-04-04
CS76692A3 (en) 1992-08-12
EP0491757A1 (en) 1992-07-01
JP2965695B2 (en) 1999-10-18
EP0593098A3 (en) 1994-04-27
ES2113347T3 (en) 1998-05-01
RU2036235C1 (en) 1995-05-27
FI99192C (en) 1997-10-27
DE122008000026I2 (en) 2011-05-05
FI920981A0 (en) 1992-03-05
ATE161681T1 (en) 1998-01-15
NO920834L (en) 1992-03-03
EP0491757B1 (en) 1998-01-07

Similar Documents

Publication Publication Date Title
AU6339190A (en) Process for inactivating viruses in blood and blood products
AU580402B2 (en) Method of inactivating viruses involving adsorption on solid phase
DE3379057D1 (en) Separation of mannose by selective adsorption on zeolitic molecular sieves
DE69111917T2 (en) Pressure swing adsorption process for the separation of gas mixtures.
FR2667800B1 (en) ADSORPTION SEPARATION PROCESS, AND ADSORBER.
ES8608877A1 (en) Process and device for the selective separation of pathological and/or toxic species from blood or plasma with the use of filter candles.
GB2337261B (en) Separation of nucleic acids
EP0168234A3 (en) Purification process for hepatitis surface antigen and product thereof
EP0416127A4 (en) Process for efficiently recovering adsorbable gas from gas which contains adsorbable gas at low concentration
CA2033215A1 (en) Purification of sulphide-containing gases
AU4521389A (en) Process for purifying blood plasma
GR3004359T3 (en)
AU2140888A (en) Purification process
AU662084B2 (en) Process for reactivating purified membrane proteins
DE68918436T2 (en) Adsorptive separation process for the purification of 2,6-dimethylnaphthalene.
MX9700290A (en) Process for the removal of dissolved metallic catalyst from ester products.
AU6748887A (en) Mercury adsorbent carbon molecular sieves and process for removing mercury vapor from gas streams

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry